Baseline effects of non-flavored e-liquids in the in vitro micronucleus assay.
Nonclinical
Genotoxicity
In Vitro
Smart (2019)
Genotoxicity evaluation of tobacco and nicotine delivery products: Part Two. In vitro micronucleus assay.
Nonclinical
Genotoxicity
In Vitro
Thorne (2019)
Genotoxicity evaluation of tobacco and nicotine delivery products: Part One. Mouse lymphoma assay.
Nonclinical
Genotoxicity
In Vitro
Thorne (2019)
a novel role for vaping in mitochondrial gene dysregulation and inflammation fundamental to disease development.
Nonclinical
Genotoxicity
In Vivo
Tommasi (2021)
Vaping Dose, Device Type, and E-Liquid Flavor are Determinants of DNa Damage in Electronic Cigarette Users.
Nonclinical
Genotoxicity
In Vivo
Tommasi (2023)
Fetal e-cigarette exposure programs a neonatal brain hypoxic-ischemic sensitive phenotype via altering DNa methylation patterns and autophagy signaling pathway.
Nonclinical
Genotoxicity
In Vivo
Walayat (2021)
Perspectives on Epigenetics alterations associated with Smoking and Vaping.
Nonclinical
Genotoxicity
In Vivo
Xie (2021)
Cigarette Smoke and Nicotine-Containing Electronic-Cigarette Vapor Downregulate Lung WWOX Expression, Which Is associated with Increased Severity of Murine acute Respiratory Distress Syndrome.
Nonclinical
Genotoxicity
In Vitro
Zeng (2021)
The Role of Messaging and Perception in Reducing Youth Vaping
Nonclinical
Genotoxicity
In Vitro
Yang (2025)